| View |
|
DRP-9197-01
|
Paracetamol
|
Aeknel
|
150 mg/ mL
|
Solution for Injection (IM/IV)
|
Analgesic/ Antipyretic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant III - Injectables)
|
India
|
CLIDP Conversion
|
19 February 2024
|
15 February 2026
|
| View |
|
DRP-9415-03
|
Iohexol
|
Prohexon 350
|
755 mg/mL (eq. to 350 mg/mL Iodine)
|
Solution for Injection
|
X-ray Contrast media, Iodinated (Watersoluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
23 December 2025
|
| View |
|
DRP-9391-07
|
Telmisartan
|
Telimac 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
18 February 2024
|
02 March 2026
|
| View |
|
DRP-9390-10
|
Telmisartan
|
Telimac 40
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics & Chemicals Ltd.
|
India
|
CLIDP Conversion
|
21 February 2024
|
02 March 2026
|
| View |
|
DRP-9390-09
|
Telmisartan
|
Medisartan
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
02 March 2026
|
| View |
|
DRP-9330-01
|
Paracetamol + Ascorbic Acid
|
Tempra Boost-C
|
500 mg/40 mg
|
Granules for Solution
|
Analgesic/Antipyretic/Vitamin
|
Interphil Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 February 2024
|
30 June 2025
|
| View |
|
DRP-9416-03
|
Iohexol
|
Hextar
|
647 mg/mL (eq. to 300mg/mL Iodine)
|
Solution for Injection
|
X-Ray Contrast Media, Iodinated (Water soluble, Nephrotropic, Low Osmolar)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 February 2024
|
23 December 2025
|
| View |
|
DRP-9668-02
|
Ceftriaxone (as sodium)
|
Gotrax
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
19 February 2024
|
27 April 2026
|
| View |
|
DRP-9688-01
|
Levocetirizine Dihydrochloride
|
Histaquest
|
5 mg
|
Film-Coated Tablet
|
Antihistamine
|
Healer's Lab (Unit II)
|
India
|
CLIDP Conversion
|
27 February 2024
|
18 May 2026
|
| View |
|
DRP-9879-02
|
Carvedilol
|
Unbranded
|
6.25 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Medley Pharmaceuticals Limited
|
India
|
Renewal
|
02 August 2024
|
25 February 2030
|
| View |
|
DRP-9975-11
|
Cefuroxime (as axetil)
|
Cefupen -5 00
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
01 July 2026
|
| View |
|
DRP-9984-04
|
Telmisartan + Hydrochlorothiazide
|
Telzyd H 80/12.5
|
80mg/12.5mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Diuretic
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
06 February 2024
|
14 June 2029
|
| View |
|
HRP-183-01
|
Ascorbic Acid + Zinc
|
Curecee Plus
|
100 mg/ 10 mg per mL
|
Syrup
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
24 January 2028
|
| View |
|
HRP-267-05
|
Povidone-Iodine
|
None
|
100 mg/mL (10% w/v)
|
Topical Solution
|
Antiseptic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
14 February 2024
|
08 February 2028
|
| View |
|
DRP-14924
|
Esomeprazole (as sodium)
|
Emeraz
|
40 mg
|
Lyophilized Powder for I.V. Injection
|
Proton pump inhibitor
|
Lyka Labs Limited
|
India
|
Initial
|
27 February 2024
|
27 February 2029
|
| View |
|
DRP-14930
|
Gliclazide
|
Proglitab MR 60
|
60mg
|
Modified-Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Inventia Healthcare Limited
|
India
|
Initial
|
27 February 2024
|
27 February 2029
|
| View |
|
DRP-14967
|
Flunarizine (as dihydrochloride)
|
Fluniz
|
5 mg
|
Capsule
|
Antivertigo
|
Ravian Life Science Pvt. Ltd.
|
India
|
Initial
|
27 February 2024
|
27 February 2029
|
| View |
|
DRP-14963
|
Thiamine (Vitamin B1)+ Pyridoxine (Vitamin B6) +
Cyanocobalamin (Vitamin B12)
|
Nervesaph-B
|
100mg/100 mg/5 mg
|
Film-Coated Tablet
|
Vitamin
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial [OTC]
|
26 February 2024
|
26 February 2029
|
| View |
|
DRP-14964
|
Mupirocin
|
Muprixine
|
20 mg/g (2% w/w)
|
Topical Ointment
|
Antibiotic for Topical Use
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
Initial [OTC]
|
07 March 2024
|
07 March 2029
|
| View |
|
DRP-5052-19
|
Cefixime (as trihydrate)
|
None
|
100mg/5mL
|
Granules For Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories
|
Philippines
|
Initial (Variation)
|
27 February 2024
|
18 August 2027
|